Nasopharyngeal carcinoma (NPC) is an epithelial tumor with a distinct geographic distribution and a characteristic histologic appearance. It is rare in Europe and North America, but it is among the most common cancers in southern China. Genetic predisposition, environmental factors, and Epstein-Barr virus (EBV) all have been associated with the pathogenesis of this tumor. There is an increasing body of evidence that among all these factors, EBV appears to be the strongest and most consistently related factor. According to the current sensitive in situ hybridization methods for the detection of EBV-encoded small RNAs (EBER), almost 100% of cases of NPC, irrespective of their histologic subtypes, have demonstrable EBERs in the nuclei of the tumor cells. In this review paper, we discuss the predisposing genetic and environmental factors and the role of EBV in the pathogenesis of this tumor with particular emphasis on the role of EBV.
Get full access to this article
View all access options for this article.
References
1.
HoJHC. Nasopharyngeal carcinoma (NPC). Adv Cancer Res1972;15: 57–92.
2.
YehSCowdryEV. Incidence of malignant tumors in Chinese. Cancer1954;7: 425–36.
3.
HuangSC. Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys1980;6: 401–40.
HsuMMHuangSCLynnTCHsiehTTuSM. The survival of patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg1982;90: 289–95.
6.
LanierABenderTTalbotM. Nasopharyngeal carcinoma in Alaskan Eskimos, Indians, and Aleuts: a review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors. Cancer1980;46: 2100–6.
7.
AltunMFandiADupuisOCvitkovicEKrajinaZEschwegeF. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. Int J Radiat Oncol Biol Phys1995;32: 859–77.
8.
MuirCSWaterhouseJMackTPowellJWhelanS, eds. Cancer incidence in five continents. Vol V. IARC Sci Publ1987;88: 1–970.
9.
BuellP. The effect of migration on the risk of nasopharyngeal cancer among Chinese. Cancer Res1974;34: 1189–91.
10.
MuirCS. Nasopharyngeal carcinoma in non-Chinese populations with special reference to south-east Asia and Africa. Int J Cancer1971;8: 351–63.
11.
BailarJC. Nasopharyngeal cancer in white populations: a worldwide survey. In: MuirCSShanmugaratnamK, eds. Cancer of the nasopharynx. New York, NY: Medical Examination Publishing Co, 1967: 18–23.
12.
EastonJMLevinePHHyamsVJ. Nasopharyngeal carcinoma in the United States. A pathologic study of 177 US and 30 foreign cases. Arch Otolaryngol1980;106: 88–91.
13.
PrasadU. Fossa of Rosenmüller and nasopharyngeal carcinoma. Med J Malaysia1979;33: 222–5.
14.
ShanmugaratnamKSobinLH. Histological typing of tumors of the upper respiratory tract and ear. 2nd ed.Berlin, Germany: Springer-Verlag, 1991: 32–3.
15.
ShanmugaratnamKChanSHde-TheG. Histopathology of nasopharyngeal carcinoma. Correlations with epidemiology, survival rates and other biological characteristics. Cancer1979;44: 1029–44.
16.
RegaudCReverchonL. Sur un cas d'epithelioma epidermoide developpe dans le massif maxillaire superieur. Rev Laryngol Otol Rhinol (Bord)1921;42: 369–78.
CarboneAMicheauC. Pitfalls in microscopic diagnosis of undifferentiated carcinoma of nasopharyngeal type (lymphoepithelioma). Cancer1982;50: 1344–51.
19.
TaxyJBHidvegiDFBattiforaH. Nasopharyngeal carcinoma. Antikeratin immunohistochemistry and electron microscopy. Am J Clin Pathol1985;83: 320–5.
20.
ShiSRGoodmanMLBhanAKPilchBZChenLBSunTT. Immunohistochemical study of nasopharyngeal carcinoma using monoclonal keratin antibodies. Am J Pathol1984; 117: 53–63.
21.
MiettinenMLehtoVPVirtanenI. Nasopharyngeal lymphoepithelioma. Histological diagnosis as aided by immunohistochemical demonstration of keratin. Virchows Arch [B]1982;40: 163–9.
22.
Ziegels-WeissmanJNadjiMPenneysNSMoralesAR. Prekeratin immunohistochemistry in the diagnosis of undifferentiated carcinoma of the nasopharyngeal type. Arch Pathol Lab Med1984;108: 588–9.
23.
PathmanathanRPrasadUSadlerRFlynnKRaab-TraubN. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med1995;333: 693–8.
24.
SimonsMJWeeGBDayNEMorrisPJShanmugaratnamKde-TheGB. Immunogenetic aspects of nasopharyngeal carcinomas: I. Difference in HL-A antigen profiles between patients and control groups. Int J Cancer1974;13: 122–34.
25.
SimonsMJWeeGBGohEH. Immunogenetic aspects of nasopharyngeal carcinoma. IV. Increased risk in Chinese of nasopharyngeal carcinoma associated with a Chinese-related HLA profile (A2, Singapore 2). J Natl Cancer Inst1976;57: 977–80.
26.
HendersonBELouieEJingJSHBuellPGardnerMB. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med1976;295: 1101–6.
27.
LuSJDayNEDegosL. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature1990;346: 470–1.
28.
ArmstrongRWArmstrongMJYuMCHendersonBE. Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res1983;43: 2967–70.
29.
YuMCMoCCChongWXYehFSHendersonBE. Preserved foods and nasopharyngeal carcinoma. A case-control study in Guangxi, China. Cancer Res1988;48: 1954–9.
30.
YuMCHoJHCLaiSHHendersonBE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res1986;46: 956–61.
31.
BouvierGHergenhahnMPolackABomkammGWde TheGBartschH. Characterization of macromolecularlignins as Epstein-Barr virus inducer in foodstuff associated with nasopharyngeal carcinoma risk. Carcinogenesis1995;16: 1879–85.
32.
HuangDPLoKWChoiPHK. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet1991;54: 91–9.
33.
ChoiPHKSuenMWMHuangDPLoKWLeeJCK. Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients. Cancer1993;72: 2873–8.
34.
HuangDPHoJHCChanWKLauWHLuiM. Cytogenetics of undifferentiated nasopharyngeal carcinoma xenografts from southern Chinese. Int J Cancer1989;43: 936–9.
35.
NiedobitekGAgathanggelouABarberPSmallmanLAJonesELYoungLS. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol1993;170: 457–61.
36.
SunYHegamyerGChengYJ. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA1992;89: 6516–20.
37.
EffertPMcCoyRAbdel-HamidM. Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol1992;66: 3768–75.
38.
LuQLEliaGLucasSThomasJA. Bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int J Cancer1993;53: 29–35.
39.
LennetteET. Epstein-Barr virus. In: BalowsAHausierWJJrShadomyHJ, eds. Manual of clinical microbiology. 4th ed.Washington, DC: American Society for Microbiology, 1985: 728–32.
40.
EpsteinMAAchongBGBarrYM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet1964; 1: 702–3.
41.
WeissLMChangKL. Association of the Epstein-Barr virus with hematoly mphoid neoplasia. Adv Anat Pathol1996;3: 1–15.
42.
EpsteinMAHenleGAchongBGBarrYM. Morphological and biological studies on a virus in cultured lymphoblasts from Burkitt's lymphoma. J Exp Med1965;121: 761–9.
43.
HummelerKHenleGHenleW. Fine structure of a virus in cultured lymphoblasts from Burkitt lymphoma. J Bacteriol1966;91: 1366–8.
44.
NonoyamaMPaganoJS. Detection of Epstein-Barr viral genome in nonproductive cells. Nature New Biol1971;233: 103–6.
45.
SchooleyRT. Epstein-Barr virus (infectious mononucleosis). In: MandellGLBennettJEDolinR, eds. Douglas and Bennett's Principles and practice of infectious disease. 4th ed.New York, NY: Churchill Livingstone, 1995: 1364–77.
46.
SixbeyJWVesterinenEHNedrudJGRaab-TraubNWaltonLAPaganoJS. Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature1983;306: 480–3.
47.
OldLJBoyseEAOettgenHF. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci USA1966;56: 1699–704.
48.
ChengHMFoongYTMathewASamCKDillnerJPrasadU. Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay. J Virol Methods1993;42: 45–51.
49.
PearsonGRWeilandLHNeelHBIII. Application of Epstein-Bait virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer1983;51: 260–8.
50.
RingborgUHenleWHenleG. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck. Cancer1983;52: 1237–43.
51.
ZongYSShamJSTNgMH. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer1992;69: 3–7.
52.
SamCKPrasadUPathmanathanR. Serological markers in the diagnosis of the histopathological types of nasopharyngeal carcinoma. Eur J Surg Oncol1989;15: 357–60.
53.
HenleWHoJHCHenleGChauJCWKwanHC. Nasopharyngeal carcinoma: significance of change in Epstein-Barr virus-related antibody patterns following therapy. Int J Cancer1977;20: 663–72.
54.
NaegeleRFChampionJMurphySHenleGHenleW. Nasopharyngeal carcinoma in American children: Epstein-Barr virus-specific antibody titers and prognosis. Int J Cancer1982; 29: 209–12.
55.
MathewAChengHMSamCKJoabIPrasadUCochetC. A high incidence of serum IgG antibodies to the Epstein-Ban virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunol Immunother1994;38: 68–70.
56.
YipTTCNganRKCLauWH. A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma. Cancer1994;74: 2414–24.
57.
zur HausenHSchulte-HolthausenHKleinG. EBV DNA in biopsies of Burkitt tumors and anaplastic carcinomas of the nasopharynx. Nature1970;228: 1056–8.
58.
NonoyamaMHuangCHPaganoJSKleinGSinghS. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci USA1973;70: 3265–8.
59.
WolfHzur HausenHBeckerV. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol1973;244: 245–7.
60.
WolfHzur HausenHKleinGBeckerVHenleGHenleW. Attempts to detect virus-specific DNA sequences in human tumors, m. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol (Bert)1975;161: 15–21.
61.
KleinGGiovanellaBCLindahlTFialkowPJSinghSStehlinJS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Nad Acad Sci USA1974;71: 4737–41.
62.
WeissLMMovahedLAButlerAE. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am J Surg Pathol1989;13: 625–31.
63.
SauerbreiAWutzierPFarberIBrichacekBSwobodaRMacheleidtS. Comparative detection of herpes viruses in tissue specimens by in situ hybridization and immunofluorescence. Acta Virol1986;30: 213–9.
64.
ChangKLChenY-YShibataDWeissLM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol1992; 1: 246–55.
65.
Hamilton-DutoitSJPallesenG. Detection of Epstein-Barr virus small RNAs in routine paraffin sections using non-isotopic RNA/RNA in situ hybridization. Histopathology1994;25: 101–11.
66.
PathmanathanRPrasadUChandrikaGSadlerRFlynnKRaab-TraubN. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol1995;146: 1355–67.
67.
NiedobitekGHansmannMLHerbstH. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol1991;165: 17–24.
68.
Raab-TraubNFlynnKPearsonG. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer1987;39: 25–9.
69.
YeungWMZongYSChiuCT. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer1993;53: 746–50.
70.
SamCKBrooksLANiedobitekGYoungLSPrasadURickinsonAB. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J Cancer1993;53: 957–62.
71.
Raab-TraubNFlynnK. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell1986;47: 883–9.
72.
Abdel-HamidMChenJJConstantineNMassoudMRaab-TraubN. EBV strain variation: geographical distribution and relation to disease state. Virology1992;190: 168–75.
73.
FahraeusRFuHLEmbergI. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer1988;42: 329–38.
74.
BrooksLYaoQYRickinsonABYoungLS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol1992;66: 2689–97.
75.
YoungLSDawsonCWClarkD. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol1988;69: 1051–65.
76.
NiedobitekGYoungLSSamCKBrooksLPrasadURickinsonAB. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol1992;140: 879–87.
77.
BussonPMcCoyRSadlerRGilliganKTurszTRaab-TraubN. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol1992;66: 3257–62.
78.
CochetCMartel-RenoirDGrunewaldV. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology1993;197: 358–65.
79.
Martel-RenoirDGrunewaldVTouitouRSchwaabGJoabI. Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J Gen Virol1995;76: 1401–8.
80.
FingerothJDWeisJJTedderTFStromingerJLBiroPAFearonDT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA1984; 81: 4510–4.
81.
NemerowGRMoldCSchwendVKTollefsonVCooperNR. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells. Sequence homology of gp350 and C3 complement fragment C3d. J Virol1987;61: 1416–20.
82.
TannerJWeisJFearonDWhangYKieffE. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptors mediates adsorption, capping andendocytosis. Cell1987;50: 203–13.
83.
YoungLSDawsonCWBrownKWRickinsonAB. Identification of human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer1989;43: 786–94.
KayeKMIzumiMKMosialosGKieffE. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation. Fibroblast cocultivation complements a critical function within the terminal 155 residues. J Virol1995;69: 675–83.
86.
WangDLiebowitzDKieffE. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell1985;43: 831–40.
87.
DawsonCWRickinsonABYoungLS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature1990;344: 777–80.
88.
NiedobitekGFahraeusRHerbstH. The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Arch [B]1992;62: 55–9.
89.
FahraeusRRymoLRhimJSKleinG. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature1990;345: 447–9.
90.
BrooksLNiedobitekGAgathanggelouAFarrellPJ. The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1. Am J Pathol1995; 146: 1102–12.
91.
KieffE. Epstein-Barr virus — increasing evidence of a link to carcinoma. N Engl J Med1995;333: 724–6.
92.
MosialosGBirkenbachMYalamanchiliRVanArsdaleTWareCKieffE. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell1995;80: 389–99.
93.
WangDLiebowitzDWangF. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype. Deletion of the amino terminus abolishes activity. J Virol1988;62: 4173–84.
94.
HuLFZabarovskyERChenF. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol1991; 72: 2399–409.
95.
ChenMLTsaiCNLiangCL. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene1992;7: 2131–40.
96.
HuLFChenFZhengX. Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene1993;8: 1575–83.
97.
MillerWEEdwardsRHWallingDMRaab-TraubN. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol1994;75: 2729–40.
98.
WaldronJVan HasseltAWongRKY. Sensitivity of biopsy using local anesthesia in detecting nasopharyngeal carcinoma. Head Neck1992;14: 24–7.
99.
Van HasseltCAJohnDG. Diagnosing nasopharyngeal cancer. Laryngoscope1994;104: 103–4.
100.
LeeAWMPoonYFFooW. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys1992;23: 261–70.
101.
BloomSM. Cancer of the nasopharynx: a study of ninety cases. J Mt Sinai Hosp1969;36: 277–98.
102.
CreelyJJJrLyonsGDJrTrailML. Cancer of the nasopharynx. A review of 114 cases. South Med J1973;66: 405–9.
103.
MillsSEFechnerRE. The nose, paranasal sinuses, and nasopharynx. In: SternbergSS, ed. Diagnostic surgical pathology. New York, NY: Raven Press, 1994: 862–4.
104.
NeelHBIIITaylorWFPearsonGR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol1985;94: 529–37.
105.
NeelHBIII. Nasopharyngeal carcinoma. Clinical presentation, diagnosis, treatment and prognosis. Otolaryngol Clin North Am1985;18: 479–90.
106.
ChenWZZhouDLLuoKS. Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC). Int J Radiat Oncol Biol Phys1989;16: 311–4.
107.
HoppeRTWilliamsJWarnkeRGoffinetDRBagshawMA. Carcinoma of the nasopharynx. The significance of histology. Int J Radiat Oncol Biol Phys1978;4: 199–205.
108.
DeckerDADrelichmanAAl-SarrafMCrissmanJReedML. Chemotherapy for nasopharyngeal carcinoma. A ten-year experience. Cancer1983;52: 602–5.
109.
RousseletGBachouchiMBussonP. Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma. J Clin Oncol1993;11: 2143–9.
